Quantitative Emphysema on Low-Dose CT Imaging of the Chest and Risk of Lung Cancer and Airflow Obstruction
Authors:
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of Veterans Affairs
- Boehringer Ingelheim
- AstraZeneca
- Genentech
- Bellerophon Therapeutics
- National Cancer Institute
- Chiesi Farmaceutici
- National Institutes of Health (K24HL138188, R44CA203050, T32HL007749)
- Sunovion
- U.S. Department of War
- Society for Academic Continuing Medical Education
- National Heart, Lung, and Blood Institute
- Novartis
- Roche
This publication has 41 references indexed in Scilit:
- Emphysema Scores Predict Death From COPD and Lung CancerChest, 2012
- Quantitative CT Assessment of Emphysema and Airways in Relation to Lung Cancer RiskRadiology, 2011
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- Quantitative Computed Tomography Analysis, Airflow Obstruction, and Lung Cancer in the Pittsburgh Lung Screening StudyJournal of Thoracic Oncology, 2011
- The National Lung Screening Trial: Overview and Study DesignRadiology, 2011
- COPD prevalence is increased in lung cancer, independent of age, sex and smoking historyEuropean Respiratory Journal, 2009
- Association of Radiographic Emphysema and Airflow Obstruction with Lung CancerAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Spirometry Utilization for COPDChest, 2007
- Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung CancerCell, 2005
- Image filtering for improved dose resolution in CT polymer gel dosimetryMedical Physics, 2003